Emily Z. Keung - Concepedia

Author

Emily Z. Keung

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

E Z Keung, E. Keung, E.Z. Keung, Emily Keung, Emily Z Keung, Emily Z. Keung, Emily Zhi-Yun Keung

212

Publications

8.4K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Brigham and Women's Hospital Memorial Sloan Kettering Cancer Center Harvard University Moffitt Cancer Center

About

Emily Z. Keung is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, oncology, and cancer research.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	16	21	3.4K
2	Health Sciences	4	4	162
3	Cell Biology	3	3	122
4	Natural Sciences	1	1	38
5	Biostatistics	1	1	48

Emily Z. Keung

Publications

7.3K

Citations

H-Index

Page 1

	Year	Citations
B cells and tertiary lymphoid structures promote immunotherapy response Beth A. Helmink, Sangeetha M. Reddy, Jianjun Gao, Nature Humoral ResponseImmunologyB CellsAutoimmunityHumoral Immunity	2020	2.5K
B cells are associated with survival and immunotherapy response in sarcoma Florent Petitprez, Aurélien de Reyniès, Emily Z. Keung, Nature	2020	1.8K
Neoadjuvant relatlimab and nivolumab in resectable melanoma Rodabe N. Amaria, Michael A. Postow, Elizabeth M. Burton, Nature	2022	312
Autoimmune antibodies correlate with immune checkpoint therapy-induced toxicities Salahaldin A. Tahir, Jianjun Gao, Yuji Miura, Proceedings of the National Academy of Sciences	2019	231
Correlative Analyses of the SARC028 Trial Reveal an Association Between Sarcoma-Associated Immune Infiltrate and Response to Pembrolizumab Emily Z. Keung, Melissa Burgess, Ruth Salazar, Clinical Cancer Research	2020	191
Comparison of Cancer Prevalence in Patients With Neurofibromatosis Type 1 at an Academic Cancer Center vs in the General Population From 1985 to 2020 Jace P. Landry, Kelsey Schertz, Yi‐Ju Chiang, JAMA Network Open	2021	159
Treatment at low‐volume hospitals is associated with reduced short‐term and long‐term outcomes for patients with retroperitoneal sarcoma Emily Z. Keung, Yi‐Ju Chiang, Janice N. Cormier, Cancer	2018	148
Clinical activity of pembrolizumab (P) in undifferentiated pleomorphic sarcoma (UPS) and dedifferentiated/pleomorphic liposarcoma (LPS): Final results of SARC028 expansion cohorts. Melissa Burgess, Vanessa Bolejack, Scott M. Schuetze, Journal of Clinical Oncology Primary EndpointImmunologyPathologyImmunotherapeuticsRefractory Ups	2019	129
Predictors of Outcomes in Patients with Primary Retroperitoneal Dedifferentiated Liposarcoma Undergoing Surgery Emily Z. Keung, Jason L. Hornick, Monica M. Bertagnolli, Journal of the American College of Surgeons	2013	127
Androgen receptor blockade promotes response to BRAF/MEK-targeted therapy Christopher P. Vellano, Michael G. White, Miles C. Andrews, Nature Hormonal ReceptorBreast CancerPharmacotherapyEndocrinologyMedicine	2022	124

Page 1